173 related articles for article (PubMed ID: 21547513)
41. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
42. Endocrine and metabolic characteristics of polycystic ovary syndrome in Chinese women with different phenotypes.
Xu X; Shi Y; Cui Y; Ma J; Che L; Chen ZJ
Clin Endocrinol (Oxf); 2012 Mar; 76(3):425-30. PubMed ID: 21815904
[TBL] [Abstract][Full Text] [Related]
43. Association of lipid profile and obesity in patients with polycystic ovary syndrome.
Parveen S; Khan S; Khan MM; Gupta B; Ahmad A; Alam R
Endocr Regul; 2024 Jan; 58(1):83-90. PubMed ID: 38656255
[No Abstract] [Full Text] [Related]
44. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
Chae SJ; Kim JJ; Choi YM; Hwang KR; Jee BC; Ku SY; Suh CS; Kim SH; Kim JG; Moon SY
Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512
[TBL] [Abstract][Full Text] [Related]
45. Studies of cardiovascular risk factors in polycystic ovary syndrome patients combined with subclinical hypothyroidism.
Pei YJ; Wang AM; Zhao Y; Yan L; Li M; White RE; Han GC
Gynecol Endocrinol; 2014 Aug; 30(8):553-6. PubMed ID: 24884959
[TBL] [Abstract][Full Text] [Related]
46. Kuntai capsules improve glucolipid metabolism in patients with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
Liang R; Liu Z; Li P; Fan P; Xu L; Sun X; Peng J; Peng X; Zhang M
Medicine (Baltimore); 2019 Sep; 98(39):e16788. PubMed ID: 31574794
[TBL] [Abstract][Full Text] [Related]
47. Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria.
Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
Arch Gynecol Obstet; 2016 Feb; 293(2):447-56. PubMed ID: 26408006
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of biochemical, endocrine, and metabolic biomarkers for the early diagnosis of polycystic ovary syndrome among non-obese Saudi women.
Daghestani MH
Int J Gynaecol Obstet; 2018 Aug; 142(2):162-169. PubMed ID: 29745981
[TBL] [Abstract][Full Text] [Related]
49. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.
Pasquali R; Gambineri A; Anconetani B; Vicennati V; Colitta D; Caramelli E; Casimirri F; Morselli-Labate AM
Clin Endocrinol (Oxf); 1999 Apr; 50(4):517-27. PubMed ID: 10468913
[TBL] [Abstract][Full Text] [Related]
50. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Wu J; Zhu Y; Jiang Y; Cao Y
Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
[TBL] [Abstract][Full Text] [Related]
51. Body Mass Index below Obesity Threshold Implies Similar Cardiovascular Risk among Various Polycystic Ovary Syndrome Phenotypes.
Bagir GS; Bakiner OS; Bozkirli E; Cavlak G; Serinsoz H; Ertorer ME
Med Princ Pract; 2016; 25(1):61-6. PubMed ID: 26335185
[TBL] [Abstract][Full Text] [Related]
52. [Clinical, hormonal and metabolic characteristics of different phenotypes of polycystic ovary syndrome, in Bulgarian population].
Kavardzhikova S; Pechlivanov B
Akush Ginekol (Sofiia); 2010; 49(4):32-7. PubMed ID: 20734639
[TBL] [Abstract][Full Text] [Related]
53. Hyperandrogenemia in polycystic ovary syndrome: exploration of the role of free testosterone and androstenedione in metabolic phenotype.
Lerchbaum E; Schwetz V; Rabe T; Giuliani A; Obermayer-Pietsch B
PLoS One; 2014; 9(10):e108263. PubMed ID: 25310562
[TBL] [Abstract][Full Text] [Related]
54. [Effect of abdominal acupuncture therapy on the endocrine and metabolism in obesity-type polycystic ovarian syndrome patients].
Lai MH; Ma HX; Yao H; Liu H; Song XH; Huang WY; Wu XK
Zhen Ci Yan Jiu; 2010 Aug; 35(4):298-302. PubMed ID: 21090334
[TBL] [Abstract][Full Text] [Related]
55. Effects of a ketogenic diet in overweight women with polycystic ovary syndrome.
Paoli A; Mancin L; Giacona MC; Bianco A; Caprio M
J Transl Med; 2020 Feb; 18(1):104. PubMed ID: 32103756
[TBL] [Abstract][Full Text] [Related]
56. Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome.
Yang Z; Zhou W; Zhou C; Zhou Y; Liu X; Ding G; Hu Y; Pan J; Sheng J; Jin L; Huang H
J Steroid Biochem Mol Biol; 2021 Feb; 206():105806. PubMed ID: 33340681
[TBL] [Abstract][Full Text] [Related]
57. Serum chemerin level in women with PCOS and its relation with the risk of spontaneous abortion.
Yang X; Quan X; Lan Y; Wei Q; Ye J; Yin X; Ji Z; Xing H; Yang Y
Gynecol Endocrinol; 2018 Oct; 34(10):864-867. PubMed ID: 29658354
[TBL] [Abstract][Full Text] [Related]
58. Comparison of fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome and women with simple obesity.
Słopień R; Lewandowski K; Kolacz E; Zawilska K; Warenik-Szymankiewicz A
Gynecol Endocrinol; 2006 Nov; 22(11):651-4. PubMed ID: 17145652
[TBL] [Abstract][Full Text] [Related]
59. Childhood obesity-related cardiovascular risk factors and carotid intima-media thickness.
Simşek E; Balta H; Balta Z; Dallar Y
Turk J Pediatr; 2010; 52(6):602-11. PubMed ID: 21428192
[TBL] [Abstract][Full Text] [Related]
60. Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS).
Barrea L; Arnone A; Annunziata G; Muscogiuri G; Laudisio D; Salzano C; Pugliese G; Colao A; Savastano S
Nutrients; 2019 Sep; 11(10):. PubMed ID: 31547562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]